1- Boch, J., H. Scholze, S. Schornack, A. Landgraf, S. Hahn, S. Kay, T. Lahaye, A. Nickstadt, and U. Bonas. 2009. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326(5959):1509-1512.
2- Buganim, Y., D. A. Faddah, and R. Jaenisch. 2013. Mechanisms and models of somatic cell reprogramming. Nature Review Genetics 14(6):427-439.
3- Bultmann, S., R. Morbitzer, C. S. Schmidt, K. Thanisch, F. Spada, J. Elsaesser, T. Lahaye, and H. Leonhardt. 2012. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Research 40(12):5368-5377.
4- Cermak, T., E. L. Doyle, M. Christian, L. Wang, Y. Zhang, C. Schmidt, J. A. Baller, N. V. Somia, A. J. Bogdanove, and D. F. Voytas. 2011. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Research 39(12):e82-e82.
5- Cong, L., R. Zhou, Y.-c. Kuo, M. Cunniff, and F. Zhang. 2012. Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nature Communications 3:968.
6- Garg, A., J. J. Lohmueller, P. A. Silver, and T. Z. Armel. 2012. Engineering synthetic TAL effectors with orthogonal target sites. Nucleic Acids Research 40(15):7584-7595.
7- Geiβler, R., H. Scholze, S. Hahn, J. Streubel, U. Bonas, S.-E. Behrens, and J. Boch. 2011. Transcriptional activators of human genes with programmable DNA-specificity. PLoS ONE 6(5):e19509.
8- Huang, B., T. Li, L. Alonso-Gonzalez, R. Gorre, S. Keatley, A. Green, P. Turner, P. K. Kallingappa, V. Verma, and B. Oback. 2011. A virus-free poly-promoter vector induces pluripotency in quiescent bovine cells under chemically defined conditions of dual kinase inhibition. PLoS ONE 6(9):e24501.
9- Imamura, M., K. Miura, K. Iwabuchi, T. Ichisaka, M. Nakagawa, J. Lee, M. Kanatsu-Shinohara, T. Shinohara, and S. Yamanaka. 2006. Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Developmental Biology 6(1):34.
10- Joung, J. K. and J. D. Sander. 2012. TALENs: a widely applicable technology for targeted genome editing. Nature Reviews Molecular Cell Biology 14(1):49-55.
11- Katoh, Y. and M. Katoh. 2005. Comparative genomics on SOX2 orthologs. Oncology Reports 14(3):797.
12- Lan, J., S. Hua, H. Zhang, Y. Song, J. Liu, and Y. Zhang. 2010. Methylation patterns in 5′ terminal regions of pluripotency-related genes in bovine in vitro fertilized and cloned embryos. Journal of Genetics and Genomics 37(5):297-304.
13- Leis, O., A. Eguiara, E. Lopez-Arribillaga, M. Alberdi, S. Hernandez-Garcia, K. Elorriaga, A. Pandiella, R. Rezola, and A. Martin. 2012. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31(11):1354-1365.
14- Li, Y., M. Cang, A. S. Lee, K. Zhang, and D. Liu. 2011. Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PLoS ONE 6(1):e15947.
15- Livak, K. J. and T. D. Schmittgen. 2001. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2− ΔΔCT Method. Methods 25(4):402-408.
16- Maeder, M. L., S. J. Linder, D. Reyon, J. F. Angstman, Y. Fu, J. D. Sander, and J. K. Joung. 2013. Robust, synergistic regulation of human gene expression using TALE activators. Nature Methods (10), 243–245.
17- Maeder, M. L., S. Thibodeau-Beganny, A. Osiak, D. A. Wright, R. M. Anthony, M. Eichtinger, T. Jiang, J. E. Foley, R. J. Winfrey, and J. A. Townsend. 2008. Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification. Molecular Cell 31(2):294-301.
18- Miller, J. C., S. Tan, G. Qiao, K. A. Barlow, J. Wang, D. F. Xia, X. Meng, D. E. Paschon, E. Leung, and S. J. Hinkley. 2010. A TALE nuclease architecture for efficient genome editing. Nature Biotechnology 29(2):143-148.
19- Morbitzer, R., P. Römer, J. Boch, and T. Lahaye. 2010. Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors. Proceedings of the National Academy of Sciences 107(50):21617-21622.
20- Page, R. L., S. Ambady, W. F. Holmes, L. Vilner, D. Kole, O. Kashpur, V. Huntress, I. Vojtic, H. Whitton, and T. Dominko. 2009. Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning and Stem Cells 11(3):417-426.
21- Perez-Pinera, P., D. G. Ousterout, J. M. Brunger, A. M. Farin, K. A. Glass, F. Guilak, G. E. Crawford, A. J. Hartemink, and C. A. Gersbach. 2013. Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nature Methods (10) 239–242.
22- Rebar, E. J., Y. Huang, R. Hickey, A. K. Nath, D. Meoli, S. Nath, B. Chen, L. Xu, Y. Liang, and A. C. Jamieson. 2002. Induction of angiogenesis in a mouse model using engineered transcription factors. Nature Medicine 8(12):1427-1432.
23- Reyon, D., S. Q. Tsai, C. Khayter, J. A. Foden, J. D. Sander, and J. K. Joung. 2012. FLASH assembly of TALENs for high-throughput genome editing. Nature Biotechnology 30(5):460-465.
24- Sander, J. D., L. Cade, C. Khayter, D. Reyon, R. T. Peterson, J. K. Joung, and J.-R. J. Yeh. 2011. Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nature Biotechnology 29(8):697.
25- Sander, J. D., P. Zaback, J. K. Joung, D. F. Voytas, and D. Dobbs. 2009. An affinity-based scoring scheme for predicting DNA-binding activities of modularly assembled zinc-finger proteins. Nucleic Acids Research 37(2):506-515.
26- Sanjana, N. E., L. Cong, Y. Zhou, M. M. Cunniff, G. Feng, and F. Zhang. 2012. A transcription activator-like effector toolbox for genome engineering. Nature Protocols 7(1):171-192.
27- Schmid-Burgk, J. L., T. Schmidt, V. Kaiser, K. Höning, and V. Hornung. 2012. A ligation-independent cloning technique for high-throughput assembly of transcription activator-like effector genes. Nature Biotechnology 31(1):76-81.
28- Snowden, A. W., L. Zhang, F. Urnov, C. Dent, Y. Jouvenot, X. Zhong, E. J. Rebar, A. C. Jamieson, H. S. Zhang, S. Tan, C. C. Case, C. O. Pabo, A. P. Wolffe, and P. D. Gregory. 2003. Repression of Vascular Endothelial Growth Factor A in Glioblastoma Cells Using Engineered Zinc Finger Transcription Factors. Cancer Research 63(24):8968-8976.
29- Takahashi, K. and S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676.
30- Tremblay, J. P., P. Chapdelaine, Z. Coulombe, and J. Rousseau. 2012. Transcription Activator-Like Effector Proteins Induce the Expression of the Frataxin Gene. Human Gene Therapy 23(8):883-890.
31- Zhang, F., L. Cong, S. Lodato, S. Kosuri, G. M. Church, and P. Arlotta. 2011. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nature Biotechnology 29(2):149-153.